On January 17, 2022, Health and Global Policy Institute (HGPI) held the second meeting of Working Group 5 on vaccine research and development for “Next Actions for the Development and Implementation of Immunization and Vaccination Policies.”
 
This meeting was the second working group meeting on the R&D and production pipeline and, based on points raised at the previous meeting, examined the next steps needed to reinforce the vaccine R&D and production pipeline in the future. A multi-stakeholder group of experts in the field deepened discussions on the pharmaceutical regulation system for vaccines and the ability of the vaccine R&D and production systems, which are undergoing rapid investigation during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic, to provide leadership and coordination.
 
To prevent the potential spread of COVID-19, this meeting was held online using a remote conferencing system.

■2021 Advisory Board Working Group 5 (Titles omitted; in alphabetical order by last name)
Members:
 Ken J. Ishii (Professor, Division of Vaccine Science, Institute of Medical Science, The University of Tokyo/ Director, International Vaccine Design Center, Institute of Medical Science)
 Masayuki Imagawa (Chief Executive, Japan Vaccine Industry Association/ Vice President & Head, Japan Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd.)
 Hiroshi Kasanuki (Specially Appointed Professor, Waseda University/ Advisor, Institute for Medical Regulatory Science, Waseda University)
 Kengo Sonoda (General Manager, Development Department, R&D Division, KM Biologics Co., Ltd.)
 Hideki Hasegawa (Director, Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases)
 Yoshiharu Matsuura (Director, Center for Infectious Disease Education and Research (CiDER))
 Shinji Matsumoto (Chair, Vaccines Working Team, EFPIA Japan) 
 Isao Miyairi (Professor, Faculty of Pediatrics, Hamamatsu University School of Medicine)
 Yoshiaki Yamagishi (Associate Professor, Medical Center of Translational Research, Department of Medical Innovation, Osaka University)

Observer:
 Yasuhiro Araki (Director, Office of Vaccine and Blood Products, Pharmaceuticals and Medical Devices Agency)

MC/Moderator
 Takahiro Sakauchi (Associate, Health and Global Policy Institute)

Event Overview
 Joji Sugawara (Manager, Health and Global Policy Institute)

■Related contents held as part of the project
– November 4, 2021 The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies”